While the debate continues about whether COVID-19 escaped from a biotech lab or emerged in a Wuhan wet market, a new study ...

Professor Julius Lucks’s device leverages advances in in vitro synthetic biology to diagnose disease in crops before the ...

CureLab Veterinary Inc, a biopharmaceutical company that develops cancer treatments for pets, announced a Regulation D ...

Wave Life Sciences stock surged over 50% today due to promising data from its Duchenne Muscular Dystrophy candidate WVE-N531.

Some people are making it their mission to get Novavax, rather than Pfizer or Moderna, for their COVID booster.

The technological innovation is an expansion of the NOBIVAC NXT platform, and a breakthrough achievement against one of the ...

Diffuse midline glioma (DMG) is a highly aggressive and fatal pediatric high-grade glioma that primarily affects critical ...

After yield and quality control of the RNA samples, we were ultimately able to profile 46 TABs with TMI, 7 TABs with ILA and 7 normal TABs with Nanostring nCounter. We also included a validation ...

A team at the Hübner and Diecke Labs at the Max Delbrück Center has shown how human and non-human primate hearts differ ...

The stock is trading at $8.18, up $2.84, gaining 53.18% on volume of over 12.4 Million shares. The stock had a days' high of $8.33.

Goldman Sachs has initiated coverage on Avidity Biosciences with a Buy rating and a $59 price target, citing ...

The national contract covers FoundationOne CDx, FoundationOne Liquid CDx, FoundationOne RNA, and FoundationOne Heme.